Sort by

Send to

Choose Destination

Search results

Items: 9


Pseudohypoaldosteronism Type 1 (arPHA1) Treated With Sodium Polystyrene Sulfonate Pretreated Milk.

Khalil ST, Cabacungan E.

Glob Pediatr Health. 2015 Jan 30;2:2333794X15569301. doi: 10.1177/2333794X15569301. No abstract available.


Maternal diet during gestation and lactation modifies the severity of salt-induced hypertension and renal injury in Dahl salt-sensitive rats.

Geurts AM, Mattson DL, Liu P, Cabacungan E, Skelton MM, Kurth TM, Yang C, Endres BT, Klotz J, Liang M, Cowley AW Jr.

Hypertension. 2015 Feb;65(2):447-55. doi: 10.1161/HYPERTENSIONAHA.114.04179.


Racial/ethnic disparities in maternal morbidities: a statewide study of labor and delivery hospitalizations in Wisconsin.

Cabacungan ET, Ngui EM, McGinley EL.

Matern Child Health J. 2012 Oct;16(7):1455-67. doi: 10.1007/s10995-011-0914-6.


Novel CYP2C9 promoter variants and assessment of their impact on gene expression.

Kramer MA, Rettie AE, Rieder MJ, Cabacungan ET, Hines RN.

Mol Pharmacol. 2008 Jun;73(6):1751-60. doi: 10.1124/mol.107.044149.


Haplotype and functional analysis of four flavin-containing monooxygenase isoform 2 (FMO2) polymorphisms in Hispanics.

Krueger SK, Siddens LK, Henderson MC, Andreasen EA, Tanguay RL, Pereira CB, Cabacungan ET, Hines RN, Ardlie KG, Williams DE.

Pharmacogenet Genomics. 2005 Apr;15(4):245-56.


Differences in FMO2*1 allelic frequency between Hispanics of Puerto Rican and Mexican descent.

Krueger SK, Siddens LK, Martin SR, Yu Z, Pereira CB, Cabacungan ET, Hines RN, Ardlie KG, Raucy JL, Williams DE.

Drug Metab Dispos. 2004 Dec;32(12):1337-40.


Genetic variability at the human FMO1 locus: significance of a basal promoter yin yang 1 element polymorphism (FMO1*6).

Hines RN, Luo Z, Hopp KA, Cabacungan ET, Koukouritaki SB, McCarver DG.

J Pharmacol Exp Ther. 2003 Sep;306(3):1210-8.


Genotyping and site-directed mutagenesis of a cytochrome P450 meander Pro-X-Arg motif critical to CYP4B1 catalysis.

Zheng YM, Henne KR, Charmley P, Kim RB, McCarver DG, Cabacungan ET, Hines RN, Rettie AE.

Toxicol Appl Pharmacol. 2003 Jan 15;186(2):119-26.

Items per page

Supplemental Content

Loading ...
Support Center